Search - tctmd.com

Displaying 881 - 900 of 1092

Sort: Relevancy | Date

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Industry News

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

July 28, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some

Caitlin E. Cox

July 25, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Industry News

Cardiome Announces Commercialization Partnership For BRINAVESS™ In Select European Markets

July 03, 2013

News Industry News

Thoratec Acquires DuraHeart® II Ventricular Assist System

July 01, 2013

News Industry News

The AHA Exclusively Endorses Simulation Based Training from Medical Simulation Corporation and Raytheon Professional Services

June 25, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Yael L. Maxwell

May 31, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

News Daily News

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

May 24, 2013

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Jason Kahn

May 22, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Industry News

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

May 21, 2013

News Daily News

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Caitlin E. Cox

May 17, 2013

Advertisement

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Cardiome Announces Commercialization Partnership For BRINAVESS™ In Select European Markets

Thoratec Acquires DuraHeart® II Ventricular Assist System

The AHA Exclusively Endorses Simulation Based Training from Medical Simulation Corporation and Raytheon Professional Services

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Registro: Mortalidad al Año Similar para la TAVR y la Cirugía en Pacientes de Riesgo Intermedio

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content